Key result
Advances in immunosuppression, donor selection, and surgical techniques have reduced early mortality and morbidity after heart transplantation, though major early complications remain a challenge.
Why the study?
Postoperative complications continue to compromise survival and quality of life in heart transplantation recipients.
This review highlights that while early mortality and morbidity after heart transplantation have decreased due to medical and surgical advances, several major early complications still require significant clinical attention.
Answers are grounded in this paper and cite their sources.
Early complications continue to compromise heart transplant outcomes; leaves open validation of reliable predictors in prospective studies.
Cardiovascular disorders remain the leading cause of death around the world. Heart transplantation is considered the only therapeutic choice defined as the gold standard strategy to manage end-stage heart failure. Nevertheless, the remaining postoperative complications compromise both the survival rate and quality of life in heart transplantation recipients. The present study aimed to review the current findings concerning the main early complications after heart transplantation, reliable predictors, diagnostic approaches, novel surgical techniques, and management strategies. The results demonstrated that significant advances in immunosuppressive pharmaceuticals, determining appropriate policies for donor acceptance, pre and post-operative treatment/care, selection of the most compatible donor with the recipient, and the suggestion of novel diagnostic and surgical techniques over the past decade had dropped the mortality and morbidity rates early after transplantation. However,marrhythmia, atrial flutter, atrial fibrillation, deep sternal wound infection along with other sites infections, low cardiac output syndrome, acute graft dysfunction, pericardial effusion, constrictive pericarditis, and acute cellular rejection could be considered as the major early complications following heart transplantations that pivotally require further investigations.
No takes yet. Share an insight, caveat, or question.
Negargar et al. (2023) conducted a review in End-stage heart failure requiring heart transplantation. Heart transplantation was evaluated on Early postoperative complications. Advances in immunosuppression, donor selection, and surgical techniques have reduced early mortality and morbidity after heart transplantation, though major early complications remain a challenge.
Synapse has enriched 10 related papers. Consider them for comparative context: